GSTM1 and Parkinson disease: Plasma aSyn levels, similar to aSyn/Hb ratios, were significantly lower in the PD group than those in the high-risk and DLB groups, and significantly higher in the DLB group than those in the low-risk group (Supplementary Fig. 2a).